Jamaican Cerasee (Momordica charantia)

Jamaican Cerasee (Momordica charantia) is a bitter vine whose primary bioactive compounds — charantin, polypeptide-p, and vicine — work together to mimic insulin activity and enhance cellular glucose uptake. These compounds act on GLUT4 translocation and AMP-activated protein kinase (AMPK) pathways to lower blood glucose levels.

Origin & History

Jamaican Cerasee is a wild cultivar variant of Momordica charantia (bitter melon) native to the West Indies and Central America, where it grows as a vine-producing fruit. It is traditionally prepared as an aqueous tea or extract by boiling or steeping the leaves, vines, or unripe fruit. This specific variant belongs to the chemical class of cucurbitane triterpenoids and charantin-like compounds.

Historical & Cultural Context

In Jamaican and West Indies folk medicine, cerasee has been used for centuries as a tea for treating diabetes mellitus. Central American traditions similarly employ it for hyperglycemia management, with usage predating modern studies and integrated into traditional bush tea practices.

Health Benefits

• Blood glucose reduction: Animal studies show up to 50% reduction in hyperglycemia after 5 hours in diabetic mice (preliminary evidence)
• Improved glucose tolerance: Chronic oral administration enhanced glucose disposal over 13 days in mice without altering insulin levels (preliminary evidence)
• Fasting glucose control: 400 mg/kg oral extract reduced fasting blood glucose in normal rats (p<0.05, preliminary evidence)
• Anti-hyperglycemic effects: 250 mg/kg showed glucose-lowering effects in type 1-like diabetic rat models via extra-pancreatic mechanisms (preliminary evidence)
• Non-insulin dependent glucose metabolism: Works through pathways independent of insulin secretion, potentially via peripheral glucose uptake (preliminary evidence)

How It Works

Charantin, a steroidal glycoside in Momordica charantia, activates AMPK signaling and promotes GLUT4 translocation to cell membranes, increasing peripheral glucose uptake independent of insulin secretion. Polypeptide-p, a plant-derived insulin mimetic, binds insulin receptors and stimulates downstream PI3K/Akt signaling to facilitate glucose disposal. Vicine and other alkaloids may additionally suppress hepatic gluconeogenesis by inhibiting glucose-6-phosphatase enzyme activity.

Scientific Research

Current evidence for Jamaican Cerasee is limited to animal studies with no human clinical trials, RCTs, or meta-analyses identified. Studies in mice showed improved glucose tolerance with aqueous extracts (n unspecified per group), while controlled rat studies (n=6 per group) demonstrated significant anti-hyperglycemic effects at 250-400 mg/kg doses. No PubMed PMIDs for human trials on this specific variant were found in the research.

Clinical Summary

Animal studies in streptozotocin-induced diabetic mice demonstrated up to 50% reduction in hyperglycemia within 5 hours of oral Cerasee administration, representing preliminary but not clinically validated evidence. Chronic oral administration over 13 days improved glucose tolerance and disposal in mice without significantly altering circulating insulin levels, suggesting peripheral rather than secretagogue mechanisms. Human clinical trials are sparse and methodologically limited, with small sample sizes and short durations, meaning current evidence cannot be directly extrapolated to humans. Overall, the evidence base remains preliminary and larger, well-controlled randomized controlled trials in humans are needed before therapeutic claims can be substantiated.

Nutritional Profile

Jamaican Cerasee (Momordica charantia) is a bitter vine whose leaves, stems, and fruit contain a diverse array of bioactive compounds. Key bioactive constituents include: charantin (a steroidal glycoside mixture of sitosteryl glucoside and stigmasteryl glucoside, found at approximately 0.1–0.2% dry weight in fruit), momordicin (bitter principle triterpenoid), momordicosides (tetracyclic triterpenoid saponins, particularly momordicoside K and L), and polypeptide-p (an insulin-like peptide found at ~0.4–0.5% in seeds). Vitamins present include vitamin C (approximately 84 mg/100g fresh fruit), vitamin A (as beta-carotene, ~6 µg RAE/100g), folate (~72 µg/100g), and small amounts of vitamin B1 (thiamine ~0.04 mg/100g), B2 (riboflavin ~0.04 mg/100g), and B3 (niacin ~0.4 mg/100g). Minerals include potassium (~296 mg/100g), calcium (~19 mg/100g), phosphorus (~31 mg/100g), magnesium (~17 mg/100g), iron (~0.43 mg/100g), and zinc (~0.8 mg/100g). Macronutrient composition per 100g fresh fruit: carbohydrates ~3.7g (of which dietary fiber ~2.8g, contributing to slowed glucose absorption), protein ~1.0g, fat ~0.17g, water ~94g. Phenolic compounds include gallic acid, caffeic acid, and quercetin derivatives (total phenolics estimated at 150–300 mg GAE/100g fresh weight). Alkaloids including momordicine are present in trace amounts. Bioavailability notes: Charantin absorption is enhanced by lipid co-ingestion due to its steroidal nature; polypeptide-p is subject to proteolytic degradation when taken orally, reducing systemic bioavailability significantly; standardized extracts at 400 mg/kg in animal models have demonstrated measurable hypoglycemic activity, suggesting sufficient oral bioavailability of at least some active fractions. Water-soluble constituents (vitamin C, phenolics) are well-absorbed but sensitive to heat processing.

Preparation & Dosage

Animal studies used aqueous extract of unripe fruit at 400 mg/kg orally for fasting glucose reduction and 250 mg/kg for anti-hyperglycemic effects. Traditional preparation involves boiling leaves, vines, or unripe fruit to make tea. No human dosage data or standardization available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cinnamon, Chromium, Alpha-lipoic acid, Gymnema sylvestre, Fenugreek

Safety & Interactions

Momordica charantia can cause hypoglycemia when combined with antidiabetic medications such as metformin, glipizide, or insulin, requiring careful blood glucose monitoring and potential dose adjustment. Vicine and convicine in Cerasee seeds can trigger hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, making it contraindicated in this population. Cerasee is considered unsafe during pregnancy due to abortifacient properties documented in animal models, and it should be avoided while breastfeeding given insufficient safety data. Common side effects include gastrointestinal distress, abdominal cramping, and diarrhea, particularly with high-dose or concentrated preparations.